Research never stops

Top Story

Evotec's partner Roche provides initial update from Phase IIb trial in Alzheimer's disease

Hamburg, Germany - 30 June 2015: Evotec AG was updated today by its partner Roche on the initial results of the Phase IIb trial with Sembragiline, a MAO-B inhibitor for the treatment of Alzheimer's disease.

- read more

Resolutions of the Annual General Meeting of Evotec AG

Hamburg - 09 June 2015: Evotec AG today announced that its shareholders approved all proposals the Company's Management put to vote at the Company's Annual General Meeting, which took place today, with the required majority.

- read more

Evotec’s approach to phenotypic screening

On the 11 June 2015 at 3 pm GMT (10 am EDT; 4 pm CET) in a free webinar, York Rudhard, Principal Scientist, and Mike Bodkin, VP Research Informatics at Evotec will provide insights into Evotec’s approach to phenotypic screening

To register and join the discussion, please click here

- read more
loading weather report
Loading weather report...


Jul 08, 2015 - Infectious Diseases World Summit

Sep 16, 2015 - Morgan Stanley Global Healthcare Conference

Company Presentation July

Building integrated and high-value drug discovery alliances
2015-07_Evotec_Company presentation_July